SCHEMBL4880285

SCHEMBL4880285

Nc1nc(N2CCOCC2)c2nc(-c3ccc(NC=O)cc3)cnc2n1.Nc1nc(N2CCOCC2)c2nc(-c3cccc(NC=O)c3)cnc2n1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS1 P29475 5/20 0.66
ATR Q13535 3/20 0.42
PIK3CG P48736 3/20 0.41
PIK3CA P42336 2/20 0.41
PIK3CB P42338 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
ADK P55263 3/20 0.41
GAK O14976 1/20 0.39
MAPK1 P28482 2/20 0.39
ABL1 P00519 1/20 0.39
NTRK1 P04629 1/20 0.39
YES1 P07947 1/20 0.39
PIM1 P11309 1/20 0.39
KDR P35968 1/20 0.39
HIPK1 Q86Z02 1/20 0.39
BRAF P15056 1/20 0.38
JAK3 P52333 1/20 0.38
USP2 O75604 1/20 0.38
LMNA P02545 1/20 0.38
CYP1A2 P05177 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3755477 0.96 NOS1 (0.68) NOS1ATRPIK3CGPIK3CAPIK3CB
SCHEMBL3755510 0.93 NOS1 (0.70) NOS1ATRPIK3CGPIK3CAADK
SCHEMBL4880291 0.90 NOS1 (0.51) NOS1ATRPIK3CGPIK3CAADK
SCHEMBL3765571 0.83 NOS1 (0.67) NOS1ATRPIK3CGPIK3CAMAPK1
SCHEMBL3755627 0.82 NOS1 (0.72) NOS1ATRPIK3CGPIK3CAPIK3CB
SCHEMBL4451911 0.81 NOS1 (0.79) NOS1ATRPIK3CGPIK3CAPIK3CB
SCHEMBL3762228 0.81 NOS1 (0.95) NOS1ATRPIK3CGPIK3CAADK
SCHEMBL4448697 0.81 NOS1 (0.63) NOS1ATRPIK3CGPIK3CAMAPK1
SCHEMBL5317835 0.81 NOS1 (1.00) NOS1PIK3CGPIK3CAADKMAPK1
SCHEMBL3768161 0.80 NOS1 (0.74) NOS1ATRPIK3CGPIK3CAADK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008009079-A2 SUBSTITUTED PTERIDINES USEFUL FOR THE TREATMENT AND PREVENTION OF VIRAL INFECTIONS GILEAD SCIENCES, INC. (US) 2008-01-24 WO disclosed